Search

Your search keyword '"Schoch, K."' showing total 214 results

Search Constraints

Start Over You searched for: Author "Schoch, K." Remove constraint Author: "Schoch, K."
214 results on '"Schoch, K."'

Search Results

1. Multi-messenger characterization of Mrk 501 during historically low X-ray and $\gamma$-ray activity

3. Multimessenger Characterization of Markarian 501 during Historically Low X-Ray and γ-Ray Activity

4. Zeigen sich Hinweise auf ein Delir in der Bildsprache? Eine systematische Analyse von Bildwerken geriatrischer Patient:innen mit und ohne Delir mittels RizbA

5. The optical behaviour of BL Lacertae at its maximum brightness levels: a blend of geometry and energetics

6. Does delirium present itself in pictorial works? A systematic analysis of pictorial works by geriatric inpatients with and without delirium

7. Association of the Family Environment with Behavioural and Cognitive Outcomes in Children with Chromosome 22q11.2 Deletion Syndrome

8. Social Skills and Associated Psychopathology in Children with Chromosome 22q11.2 Deletion Syndrome: Implications for Interventions

9. Multiwavelength Observations of the Blazar VER J0521+211 during an Elevated TeV Gamma-Ray State

16. Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome

17. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor beta Signaling

20. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion

21. Understanding Adult Participant and Parent Empowerment Prior to Evaluation in the Undiagnosed Diseases Network

23. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region

24. Loss of tubulin deglutamylase CCP1 causes infantile-onset neurodegeneration

31. Phthalocyanine semiconductor sensors for room-temperature ppb level detection of toxic gases.

32. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype [Correction]

33. Annotating pathogenic non-coding variants in genic regions

35. A tale worth telling: the impact of the diagnosis experience on disclosure of genetic disorders: Impact of the diagnosis experience on disclosure

36. De Novo Mutations in SON Disrupt RNA Splicing of Genes Essential for Brain Development and Metabolism, Causing an Intellectual-Disability Syndrome

37. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype

38. De Novo Mutations in SON Disrupt RNA Splicing of Genes Essential for Brain Development and Metabolism, Causing an Intellectual-Disability Syndrome

39. Association of the family environment with behavioural and cognitive outcomes in children with chromosome 22q11.2 deletion syndrome

40. Exome sequencing results in successful riboflavin treatment of a rapidly progressive neurological condition

41. Sustained therapeutic response to riboflavin in a child with a progressive neurological condition, diagnosed by whole-exome sequencing

42. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome

Catalog

Books, media, physical & digital resources